首页> 外文OA文献 >Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial NCT00256139

【2h】

Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial NCT00256139

机译：依法利珠单抗对高需求牛皮癣患者报告的结局的影响：Raptiva（CLEAR）试验获得的国际，随机，安慰剂对照的III期临床经验的结果NCT00256139

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Jean-Paul Ortonne; null null; Neil Shear; Stephen Shumack; Eric Henninger;
展开▼
作者单位

展开▼
年度 2005
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139] [J] . Jean-Paul Ortonne, Neil Shear, Stephen Shumack, BMC Dermatology . 2005,第1期

机译：依法珠单抗对高需求牛皮癣患者报告的结局的影响：Raptiva（CLEAR）试验获得的国际，随机，安慰剂对照的III期临床经验的结果[NCT00256139]
2. Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part I. [J] . Pariser DM, Gordon KB, Papp KA, Journal of cutaneous medicine and surgery . 2005,第6期

机译：efalizumab在慢性斑块状牛皮癣患者中的临床疗效：来自三项随机安慰剂对照的III期临床试验的结果：第一部分。
3. Patient-Reported Outcomes and the Association With Clinical Response in Patients With Active Psoriatic Arthritis Treated With Golimumab: Findings Through 2 Years of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial [J] . Kavanaugh Arthur, McInnes Iain B., Krueger Gerald G., Arthritis care & research . 2013,第10期

机译：患者报告的结果和与Golimumab治疗的活性银屑病关节炎患者临床反应的关联：通过2年的III，多中心，随机，双盲，安慰剂对照试验
4. Recruitment, retention and compliance in randomized, phase III clinical trials involving obese patients diagnosed with type 2 Diabetes Mellitus with respect to weight loss practicum report. [D] . Mithani, Moez S. 2012

机译：涉及诊断为2型糖尿病的肥胖患者的有关减肥实践的随机III期临床试验中的招募，保留和依从性报告。
5. Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international randomized placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial NCT00256139 [O] . Jean-Paul Ortonne, Neil Shear, Stephen Shumack, 2005

机译：依法利珠单抗对高需求牛皮癣患者报告的结局的影响：Raptiva（CLEAR）试验获得的国际随机安慰剂对照的III期临床经验的结果NCT00256139
6. Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139] [O] . Shumack Stephen, Shear Neil, Ortonne Jean-Paul, 2005

机译：efalizumab对高需要的银屑病患者的患者报告结果的影响：国际，随机，安慰剂对照的Raptiva（CLEaR）试验获得的III期临床经验的结果[NCT00256139]

Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial NCT00256139

著录项

相似文献

相关主题

期刊订阅